AGP
EW icon

Aspire Growth Partners’s Edwards Lifesciences EW Stock Holding History

Aspire Growth Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$358K Buy
+3,963
New +$332K 0.21% 88
2026
Q1 		– Sell
-3,137
Closed -$267K – 122
2025
Q4 		$267K Sell
3,137
-19
-0.6% -$1.56K 0.19% 101
2025
Q3 		$245K Buy
3,156
+49
+2% +$3.83K 0.18% 104
2025
Q2 		$243K Sell
3,107
-64
-2% -$4.77K 0.2% 101
2025
Q1 		$238K Sell
3,171
-28
-0.9% -$2K 0.21% 101
2024
Q4 		$237K Buy
+3,199
New +$224K 0.23% 90

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Aspire Growth Partners's EW Position: Q2 2026 in Review

Aspire Growth Partners opened a new position in Edwards Lifesciences (EW) in Q2 2026: 3,963 shares worth $358K. The stake represents 0.21% of the portfolio and ranks #88 among its holdings. This is a return to the name: Aspire Growth Partners previously reported a position in EW as recently as Q4 2025.

Aspire Growth Partners first reported a position in EW in Q4 2024 and has held it in 6 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Aspire Growth Partners held 3,963 shares of Edwards Lifesciences worth $358K as of Q2 2026.
  • Edwards Lifesciences was a new Aspire Growth Partners position in Q2 2026.
  • Edwards Lifesciences made up 0.21% of Aspire Growth Partners's portfolio in Q2 2026, its #88 holding.
  • Aspire Growth Partners first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 6 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Aspire Growth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.